Form 8-K - Current report:
SEC Accession No. 0000950170-25-066440
Filing Date
2025-05-08
Accepted
2025-05-08 08:35:07
Documents
13
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K alxo-20250508.htm   iXBRL 8-K 55119
2 EX-99.1 alxo-ex99_1.htm EX-99.1 142666
3 GRAPHIC img62044099_0.jpg GRAPHIC 149162
  Complete submission text file 0000950170-25-066440.txt   529298

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alxo-20250508.xsd EX-101.SCH 26051
15 EXTRACTED XBRL INSTANCE DOCUMENT alxo-20250508_htm.xml XML 4537
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 25924061
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)